Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis

被引:31
|
作者
Jinnin, M [1 ]
Ihn, H [1 ]
Yamane, K [1 ]
Asano, Y [1 ]
Yazawa, N [1 ]
Tamaki, K [1 ]
机构
[1] Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan
关键词
eosinophilic fasciitis; matrix metalloproteinase; systemic sclerosis;
D O I
10.1111/j.1365-2133.2004.06062.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Serum levels of tissue inhibitor of metalloproteinases (TIMPs) have been reported to be elevated in patients with various connective tissue diseases. However, there has been no report that evaluates TIMPs in patients with eosinophilic fasciitis (EF). Objectives To determine serum TIMP-1 and TIMP-2 levels in patients with EF and to investigate their clinical significance. Methods Immunohistochemical stainings were performed in normal and EF skin samples. Serum TIMP-1 and TIMP-2 levels of 11 patients with EF and 12 healthy individuals were also measured with specific enzyme-linked immunosorbent assays. Results The fascia of EF patients was stained only by TIMP-1. Serum TIMP-1 levels (mean +/- SD) were significantly higher in EF patients than in healthy individuals (206.3 +/- 65.4 vs. 145.2 +/- 36.2 ng mL(-1), P < 0.01). Serum TIMP-1 levels in EF patients were significantly correlated with serum gamma-globulin and IgG levels (r = 0.86, P < 0.05; r = 0.83, P < 0.005, respectively). Conclusions These results suggest that TIMP-1 is involved in the pathogenesis of EF, and that TIMP-1 may be a useful marker for the disease activity as well as serum gamma-globulin or IgG levels.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [41] Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction
    Kelly, Dominic
    Khan, Sohail Q.
    Thompson, Matt
    Cockerill, Gillian
    Ng, Leong L.
    Samani, Nilesh
    Squire, Iain B.
    EUROPEAN HEART JOURNAL, 2008, 29 (17) : 2116 - 2124
  • [42] Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit
    Uemura, Kazunori
    Li, Meihua
    Tsutsumi, Takaki
    Yamazaki, Toji
    Kawada, Toru
    Kamiya, Atsunori
    Inagaki, Masashi
    Sunagawa, Kenji
    Sugimachi, Masaru
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (04): : H2254 - H2261
  • [43] Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation
    Nakashima, A
    Tamura, M
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 1667 - 1678
  • [44] Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells
    Dong, Z
    Nemeth, JA
    Cher, ML
    Palmer, KC
    Bright, RC
    Fridman, R
    INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) : 507 - 515
  • [45] Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma
    Hoshino, M
    Takahashi, M
    Takai, Y
    Sim, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (02) : 356 - 363
  • [46] Ratio of Metalloproteinase 2 to Tissue Inhibitor of Metalloproteinase 2 in Medullary Thyroid Carcinoma
    Cavalheiro, Beatriz Godoi
    Junqueira, Consuelo Rodrigues
    Brandao, Lenine Garcia
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (08) : 812 - 817
  • [47] Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer
    I. Kirman
    S. Jain
    V. Cekic
    A. Belizon
    E. Balik
    P. Sylla
    T. Arnell
    K. A. Forde
    R. L. Whelan
    Surgical Endoscopy And Other Interventional Techniques, 2006, 20 : 482 - 486
  • [48] Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer
    Kirman, I
    Jain, S
    Cekic, V
    Belizon, A
    Balik, E
    Sylla, P
    Arnell, T
    Forde, K
    Whelan, RL
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2006, 20 (03): : 482 - 486
  • [49] DISTINCT PATTERN OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 MESSENGER-RNA EXPRESSION IN HUMAN COLORECTAL-CANCER AND LIVER METASTASES
    ZENG, ZS
    GUILLEM, JG
    BRITISH JOURNAL OF CANCER, 1995, 72 (03) : 575 - 582
  • [50] Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery
    Furman, C
    Luo, Z
    Walsh, K
    Duverger, N
    Copin, C
    Fruchart, JC
    Rouis, M
    FEBS LETTERS, 2002, 531 (02) : 122 - 126